Search Results 851-860 of 18061 for Alcoholics

1. A Study to Evaluate Chemoradiotherapy with or without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer - Mayo Clinic

   ... alcoholic or other autoimmune hepatitis, cirrhosis or inherited liver disease). Patients must have adequate renal function as evidenced by calculated ...

2. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

3. Liver transplant - Doctors & Departments - Mayo Clinic

   Related. Acute liver failure · Alcoholic hepatitis (Alcohol-associated hepatitis) · Alpha-1-antitrypsin deficiency · Amyloidosis · Autoimmune hepatitis ...

4. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

   s, Liver problems, Primary sclerosing cholangitis, Cholangiocarcinoma, Liver cancer, Alcoholic hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, ...

5. Surgery - Doctors - Mayo Clinic

   ... Alcoholic hepatitis, Hepatopulmonary syndrome, Hemochromatosis, Liver disease, Esophageal varices, Hepatic encephalopathy, Portal hypertension ...

6. Surgery - Doctors - Mayo Clinic

   ... Alcoholic hepatitis, Liver cancer, Fatty liver disease, End-stage liver disease, Kidney failure, Kidney disease. Show more areas of focus for Randi J. Ryan ...

7. A Study Validating the "Foods for Health" Portfolio of Functional Food Products, for People Unable to take Statin Drugs - Mayo Clinic

   Consumption of more than 2 alcoholic drink/day or history of alcoholism or drug dependence; Smokes; History of non-skin cancer; History of melanoma; History of ...

8. A Study to Evaluate Docetaxel With or Without Bintrafusp Alfa to Treat Patients with Advanced Non-small Cell Lung Cancer - Mayo Clinic

   Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis; cirrhosis; fatty liver; and inherited liver disease.

9. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis; cirrhosis; fatty liver; and inherited liver disease.

10. A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors - Mayo Clinic

    Known clinically significant liver disease, including active viral, alcoholic, or other hepatitis, cirrhosis, fatty liver, and inherited liver disease ( ...